Atrial natriuretic peptide increases human capillary filtration and venous distensibility.

Atrial natriuretic peptide augments forearm capillary filtration in humans.

Sibjotang Increases Atrial Natriuretic Peptide Secretion in Beating Rabbit Atria.

Atrial natriuretic peptide inhibits oxidant-induced increases in endothelial permeability.

Atrial natriuretic peptide.

Thyrotropin-releasing hormone increases plasma atrial natriuretic peptide levels in human.

Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide.

Effects of atrial natriuretic peptide on glomerular filtration rate in essential hypertension: a radionuclide study.

In vitro stability of human atrial natriuretic peptide (h-ANP).

Atrial natriuretic peptide is synthesized in the human thymus.

cDNA sequence of the human atrial natriuretic peptide clearance receptor.

Atrial natriuretic peptide receptors in human endometrial stromal cells.

Renal disposal of human atrial natriuretic peptide in man.

Measuring B-Type Natriuretic Peptide From Capillary Blood or Venous Sample: Is It the Same?

Inhaled atrial natriuretic peptide and asthmatic airways.

Atrial natriuretic factor and related peptide hormones.

Atrial natriuretic peptide and ciclosporin nephrotoxicity.

Hypervolemia increases release of atrial natriuretic peptide and shedding of the endothelial glycocalyx.

Atrial natriuretic peptide vs. N-terminal-pro-atrial natriuretic peptide for the detection of left atrial dilatation in horses.

Diverse biological actions of atrial natriuretic peptide.

Atrial natriuretic peptide hormonal system in plants.

Atrial natriuretic peptide in bronchial asthma.

Atrial natriuretic peptide in Cushing's disease.

Plasma atrial natriuretic peptide in elite runners.

24-hour variation in atrial natriuretic peptide.

Suggest Documents

Atrial natriuretic peptide augments forearm capillary filtration in humans.

Sibjotang Increases Atrial Natriuretic Peptide Secretion in Beating Rabbit Atria.

Atrial natriuretic peptide inhibits oxidant-induced increases in endothelial permeability.

Atrial natriuretic peptide.

Thyrotropin-releasing hormone increases plasma atrial natriuretic peptide levels in human.

Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide.

Effects of atrial natriuretic peptide on glomerular filtration rate in essential hypertension: a radionuclide study.

In vitro stability of human atrial natriuretic peptide (h-ANP).

Atrial natriuretic peptide is synthesized in the human thymus.

cDNA sequence of the human atrial natriuretic peptide clearance receptor.

Atrial natriuretic peptide receptors in human endometrial stromal cells.

Renal disposal of human atrial natriuretic peptide in man.

Measuring B-Type Natriuretic Peptide From Capillary Blood or Venous Sample: Is It the Same?

Inhaled atrial natriuretic peptide and asthmatic airways.

Atrial natriuretic factor and related peptide hormones.

Atrial natriuretic peptide and ciclosporin nephrotoxicity.

Hypervolemia increases release of atrial natriuretic peptide and shedding of the endothelial glycocalyx.

Atrial natriuretic peptide vs. N-terminal-pro-atrial natriuretic peptide for the detection of left atrial dilatation in horses.

Diverse biological actions of atrial natriuretic peptide.

Atrial natriuretic peptide hormonal system in plants.

Atrial natriuretic peptide in bronchial asthma.

Atrial natriuretic peptide in Cushing's disease.

Plasma atrial natriuretic peptide in elite runners.

24-hour variation in atrial natriuretic peptide.

Atrial natriuretic peptide increases human capillary filtration and venous distensibility.

Recommend Documents

Follow Us